Price
CHART BY
Frequently asked questions
What is Vyome Holdings, Inc.'s market capitalization?
The market capitalization of Vyome Holdings, Inc. is $27.85M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Vyome Holdings, Inc.?
Vyome Holdings, Inc.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$485.03. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Vyome Holdings, Inc.'s stock?
Currently, 1 analysts cover Vyome Holdings, Inc.'s stock, with a consensus target price of $15.00. Analyst ratings provide insights into the stock's expected performance.
What is Vyome Holdings, Inc.'s revenue over the trailing twelve months?
Over the trailing twelve months, Vyome Holdings, Inc. reported a revenue of $6.45M.
What is the EBITDA for Vyome Holdings, Inc.?
Vyome Holdings, Inc.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$6.27M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Vyome Holdings, Inc.?
Vyome Holdings, Inc. has a free cash flow of -$7.71M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Vyome Holdings, Inc. have, and what sector and industry does it belong to?
Vyome Holdings, Inc. employs approximately 18 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Vyome Holdings, Inc.'s shares?
The free float of Vyome Holdings, Inc. is 5.49M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $27.85M
- EPS (TTM)
- -$485.03
- Free Float
- 5.49M
- Revenue (TTM)
- $6.45M
- EBITDA (TTM)
- -$6.27M
- Free Cashflow (TTM)
- -$7.71M
Pricing
- 52W span
- $5.04$720.00
Analyst Ratings
The price target is $15.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. It focuses on therapeutic solutions that target formulations for site-targeted applications. The company was founded on January 2, 2008 and is headquartered in San Clemente, CA.
- Employees
- 18
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- RSLS
Fundamentals & EOD data from FactSet